SK9772003A3 - R- a S-enantiomér 2-amino-1-(4-hydroxy-3- metánsulfónamidofenyl)etanolu, farmaceutický prostriedok s ich obsahom a ich použitie - Google Patents

R- a S-enantiomér 2-amino-1-(4-hydroxy-3- metánsulfónamidofenyl)etanolu, farmaceutický prostriedok s ich obsahom a ich použitie Download PDF

Info

Publication number
SK9772003A3
SK9772003A3 SK977-2003A SK9772003A SK9772003A3 SK 9772003 A3 SK9772003 A3 SK 9772003A3 SK 9772003 A SK9772003 A SK 9772003A SK 9772003 A3 SK9772003 A3 SK 9772003A3
Authority
SK
Slovakia
Prior art keywords
pharmaceutical
enantiomer
pharmaceutical composition
pharmaceutically acceptable
acceptable salt
Prior art date
Application number
SK977-2003A
Other languages
English (en)
Slovak (sk)
Inventor
Pascale Pouzet
Franz Esser
Hisato Kitagawa
Naoki Ishiguro
Ikunobu Muramatsu
Original Assignee
Boehringer Ingelheim Pharma Gmbh & Co. Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma Gmbh & Co. Kg filed Critical Boehringer Ingelheim Pharma Gmbh & Co. Kg
Publication of SK9772003A3 publication Critical patent/SK9772003A3/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/30—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/31—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atoms of the sulfonamide groups bound to acyclic carbon atoms
    • C07C311/35—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atoms of the sulfonamide groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SK977-2003A 2001-02-01 2002-01-15 R- a S-enantiomér 2-amino-1-(4-hydroxy-3- metánsulfónamidofenyl)etanolu, farmaceutický prostriedok s ich obsahom a ich použitie SK9772003A3 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10104369A DE10104369A1 (de) 2001-02-01 2001-02-01 Verwendung von 2-Amino-(4-hydroxy-2-methansulfonamidophenyl)ethanol zur Behandlung der Harninkontinenz
PCT/EP2002/000311 WO2002060421A2 (en) 2001-02-01 2002-01-15 Use of 2-amino-1(4-hydroxy-2-methanesulphonamidophenyl)ethanol for treating urinary incontinence

Publications (1)

Publication Number Publication Date
SK9772003A3 true SK9772003A3 (sk) 2005-03-04

Family

ID=7672382

Family Applications (1)

Application Number Title Priority Date Filing Date
SK977-2003A SK9772003A3 (sk) 2001-02-01 2002-01-15 R- a S-enantiomér 2-amino-1-(4-hydroxy-3- metánsulfónamidofenyl)etanolu, farmaceutický prostriedok s ich obsahom a ich použitie

Country Status (26)

Country Link
EP (1) EP1363614B1 (ja)
JP (1) JP2004517158A (ja)
KR (1) KR20030075173A (ja)
CN (1) CN1489459A (ja)
AR (1) AR035778A1 (ja)
AT (1) ATE293966T1 (ja)
BG (1) BG108033A (ja)
BR (1) BR0206854A (ja)
CA (1) CA2434565A1 (ja)
CZ (1) CZ20032097A3 (ja)
DE (2) DE10104369A1 (ja)
DK (1) DK1363614T3 (ja)
EA (1) EA200300789A1 (ja)
EC (1) ECSP034684A (ja)
EE (1) EE200300357A (ja)
ES (1) ES2240708T3 (ja)
HU (1) HUP0302752A2 (ja)
IL (1) IL156730A0 (ja)
MX (1) MXPA03006816A (ja)
NO (1) NO20033428L (ja)
PL (1) PL361731A1 (ja)
PT (1) PT1363614E (ja)
SK (1) SK9772003A3 (ja)
UY (1) UY27145A1 (ja)
WO (1) WO2002060421A2 (ja)
ZA (1) ZA200305201B (ja)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10352132A1 (de) * 2003-11-04 2005-06-09 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pharmazeutische Zusammensetzung aus einem Beta-3-Adrenozeptor-Agonisten und einem Alpha Agonisten
JP6486359B2 (ja) * 2013-08-19 2019-03-20 タリス バイオメディカル エルエルシー 多ユニット薬物送達デバイス及び方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US341584A (en) * 1886-05-11 Device foe
FR148F (ja) * 1962-01-24
DE69113466T2 (de) * 1990-02-07 1996-03-14 Nippon Shinyaku Co Ltd Sulfonanilidderivat und arzneimittel.
DE19514579A1 (de) * 1995-04-20 1996-10-24 Boehringer Ingelheim Kg Verwendung von alpha¶1¶¶L¶-Agonisten zur Behandlung der Harninkontinenz
EP0835107A1 (en) * 1995-06-02 1998-04-15 Synaptic Pharmaceutical Corporation The use of alpha-1c-selective adrenoceptor agonists for the treatment of urinary incontinence
FR2737494B1 (fr) * 1995-08-04 1997-08-29 Synthelabo Derives de benzenesulfonamide, leur preparation et leur application en therapeutique
WO2000010557A1 (fr) * 1998-08-25 2000-03-02 Nippon Shinyaku Co.,Ltd. Preparations solides stabilisees

Also Published As

Publication number Publication date
UY27145A1 (es) 2002-08-30
CN1489459A (zh) 2004-04-14
MXPA03006816A (es) 2004-05-14
DE60203882D1 (de) 2005-06-02
DK1363614T3 (da) 2005-05-30
HUP0302752A2 (hu) 2003-11-28
PL361731A1 (en) 2004-10-04
NO20033428D0 (no) 2003-07-31
BG108033A (en) 2004-12-30
NO20033428L (no) 2003-09-30
EA200300789A1 (ru) 2004-02-26
WO2002060421A3 (en) 2002-12-19
CZ20032097A3 (cs) 2003-12-17
ES2240708T3 (es) 2005-10-16
JP2004517158A (ja) 2004-06-10
WO2002060421A2 (en) 2002-08-08
ZA200305201B (en) 2004-05-17
EE200300357A (et) 2003-10-15
EP1363614B1 (en) 2005-04-27
ECSP034684A (es) 2003-08-29
PT1363614E (pt) 2005-06-30
DE10104369A1 (de) 2002-08-08
BR0206854A (pt) 2004-01-13
EP1363614A2 (en) 2003-11-26
KR20030075173A (ko) 2003-09-22
CA2434565A1 (en) 2002-08-08
DE60203882T2 (de) 2006-02-02
IL156730A0 (en) 2004-02-08
AR035778A1 (es) 2004-07-14
ATE293966T1 (de) 2005-05-15

Similar Documents

Publication Publication Date Title
US20070155679A1 (en) Use of bradycardiac substances in the treatment of myocardial diseases associated with hypertrophy and novel medicament combinations
US20040234593A1 (en) Diphenhydramine tannate compositions and methods of use
ZA200503282B (en) Pharmaceutical composition comrpising a beta-3-adrenoceptor agonist and a serotonin and/or norepinephrine reuptake inhibitor and the use of said composition for treating bladder dysfunction
RU2238726C2 (ru) Применение саредутанта и его фармацевтически приемлемых солей для приготовления лекарственных продуктов, которые полезны при лечении или предупреждении больших депрессивных расстройств
US6525084B2 (en) Stable pharmaceutical formulation
WO2000004880A1 (en) A wet granulation method for preparing a stable pharmaceutical formulation
SK9772003A3 (sk) R- a S-enantiomér 2-amino-1-(4-hydroxy-3- metánsulfónamidofenyl)etanolu, farmaceutický prostriedok s ich obsahom a ich použitie
JP4166433B2 (ja) ホルモン依存性疾患治療剤
US6660772B2 (en) Use of 2-amino-1-(4-hydroxy-2-methanesulfonamidophenyl)ethanol for treating urinary incontinence
EP1333028A1 (en) 2'-Halo-3',5'-dialkoxyphen-1'-yl-imino-2-imidazolidine derivatives and the use thereof for the treatment of urinary incontinence
SK14552001A3 (sk) Použitie osanetantu na prípravu farmaceutických prostriedkov použiteľných na liečenie porúch nálady
WO2003086346A1 (en) Diphenhydramine tannate compositions and methods of use
RU2342133C2 (ru) Применение производных феноксиуксусной кислоты для лечения гиперактивности мочевого пузыря
AU2002228045A1 (en) Use of 2-amino-1(4-hydroxy-2-methanesulphonamidophenyl)ethanol for treating urinary incontinence
US6703409B2 (en) 2′-Halo-3′,5′-dialkoxyphen-1′-yl-imino-2-imidazolidine and the use thereof as a drug
CN115400109A (zh) 酪胺及其衍生物在制备治疗抑郁症药物中的应用
CN100518731C (zh) 苯氧基乙酸衍生物用于制备治疗机能亢进性膀胱的药物
JP2007509868A (ja) 緊張性尿失禁及び／又は混合型尿失禁治療用医薬組成物
CN1241140A (zh) 性功能障碍的治疗